Redwood Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-185,492
Closed -$9.64M 126
2018
Q4
$9.64M Buy
+185,492
New +$9.97M 0.91% 51
2017
Q3
Sell
-19
Closed -$1K 134
2017
Q2
$1K Hold
19
﹤0.01% 165
2017
Q1
$1K Hold
19
﹤0.01% 176
2016
Q4
$1K Sell
19
-391,235
-100% -$21.4M ﹤0.01% 165
2016
Q3
$21.1M Buy
391,254
+72,879
+23% +$4.68M 1.61% 17
2016
Q2
$23.4M Buy
318,375
+24,692
+8% +$1.74M 2.15% 7
2016
Q1
$18.8M Buy
+293,683
New +$18.5M 1.87% 17

Other funds holding BMY

Redwood Investments's BMY Position: Q1 2019 in Review

Redwood Investments sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 185,492 shares — an estimated $9.64M sold.

Redwood Investments first reported a position in BMY in Q1 2016 and held it in 7 quarters. The position peaked at $23.4M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Redwood Investments reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Redwood Investments sold 185,492 Bristol-Myers Squibb shares in Q1 2019, an estimated $9.64M.
  • Redwood Investments first reported a position in Bristol-Myers Squibb in Q1 2016 and held it in 7 quarters.
  • Redwood Investments's Bristol-Myers Squibb position peaked at $23.4M in Q2 2016.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Redwood Investments's 13F filing for Q1 2019, filed 7 May 2019.